nodes	percent_of_prediction	percent_of_DWPC	metapath
Apixaban—ABCB1—kidney cancer	0.161	1	CbGaD
Apixaban—CYP3A5—Temsirolimus—kidney cancer	0.0376	0.0631	CbGbCtD
Apixaban—ABCG2—Pazopanib—kidney cancer	0.0357	0.0599	CbGbCtD
Apixaban—ABCG2—Dactinomycin—kidney cancer	0.0326	0.0548	CbGbCtD
Apixaban—ABCG2—Erlotinib—kidney cancer	0.0255	0.0427	CbGbCtD
Apixaban—ABCB1—Temsirolimus—kidney cancer	0.0245	0.0411	CbGbCtD
Apixaban—ABCG2—Paclitaxel—kidney cancer	0.0233	0.0391	CbGbCtD
Apixaban—CYP3A4—Everolimus—kidney cancer	0.0217	0.0365	CbGbCtD
Apixaban—ABCG2—Sorafenib—kidney cancer	0.0207	0.0347	CbGbCtD
Apixaban—ABCG2—Vincristine—kidney cancer	0.0201	0.0337	CbGbCtD
Apixaban—CYP2C8—Pazopanib—kidney cancer	0.019	0.0319	CbGbCtD
Apixaban—ABCG2—Sunitinib—kidney cancer	0.0168	0.0281	CbGbCtD
Apixaban—CYP1A2—Pazopanib—kidney cancer	0.0147	0.0247	CbGbCtD
Apixaban—CYP3A4—Temsirolimus—kidney cancer	0.0147	0.0246	CbGbCtD
Apixaban—CYP3A5—Erlotinib—kidney cancer	0.0141	0.0237	CbGbCtD
Apixaban—CYP2C9—Capecitabine—kidney cancer	0.0138	0.0232	CbGbCtD
Apixaban—CYP2C8—Erlotinib—kidney cancer	0.0136	0.0228	CbGbCtD
Apixaban—CYP3A5—Paclitaxel—kidney cancer	0.0129	0.0217	CbGbCtD
Apixaban—ABCB1—Pazopanib—kidney cancer	0.0129	0.0216	CbGbCtD
Apixaban—ABCG2—Doxorubicin—kidney cancer	0.0126	0.0211	CbGbCtD
Apixaban—CYP2C8—Paclitaxel—kidney cancer	0.0124	0.0208	CbGbCtD
Apixaban—ABCB1—Dactinomycin—kidney cancer	0.0118	0.0197	CbGbCtD
Apixaban—CYP3A5—Sorafenib—kidney cancer	0.0115	0.0192	CbGbCtD
Apixaban—CYP3A5—Vincristine—kidney cancer	0.0111	0.0187	CbGbCtD
Apixaban—CYP2C8—Sorafenib—kidney cancer	0.011	0.0185	CbGbCtD
Apixaban—CYP1A2—Erlotinib—kidney cancer	0.0105	0.0176	CbGbCtD
Apixaban—ABCB1—Gemcitabine—kidney cancer	0.0093	0.0156	CbGbCtD
Apixaban—CYP3A5—Sunitinib—kidney cancer	0.00929	0.0156	CbGbCtD
Apixaban—CYP2C19—Sorafenib—kidney cancer	0.00925	0.0155	CbGbCtD
Apixaban—ABCB1—Erlotinib—kidney cancer	0.00918	0.0154	CbGbCtD
Apixaban—CYP2C9—Paclitaxel—kidney cancer	0.00866	0.0145	CbGbCtD
Apixaban—CYP1A2—Sorafenib—kidney cancer	0.00853	0.0143	CbGbCtD
Apixaban—ABCB1—Paclitaxel—kidney cancer	0.0084	0.0141	CbGbCtD
Apixaban—CYP3A4—Pazopanib—kidney cancer	0.00771	0.0129	CbGbCtD
Apixaban—CYP2C9—Sorafenib—kidney cancer	0.00769	0.0129	CbGbCtD
Apixaban—ABCB1—Sorafenib—kidney cancer	0.00746	0.0125	CbGbCtD
Apixaban—ABCB1—Vinblastine—kidney cancer	0.00737	0.0124	CbGbCtD
Apixaban—ABCB1—Vincristine—kidney cancer	0.00724	0.0122	CbGbCtD
Apixaban—ABCB1—Sunitinib—kidney cancer	0.00605	0.0101	CbGbCtD
Apixaban—CYP3A4—Erlotinib—kidney cancer	0.0055	0.00923	CbGbCtD
Apixaban—CYP3A4—Paclitaxel—kidney cancer	0.00503	0.00845	CbGbCtD
Apixaban—ABCB1—Doxorubicin—kidney cancer	0.00453	0.0076	CbGbCtD
Apixaban—CYP3A4—Sorafenib—kidney cancer	0.00447	0.0075	CbGbCtD
Apixaban—CYP3A4—Vinblastine—kidney cancer	0.00442	0.00741	CbGbCtD
Apixaban—CYP3A4—Vincristine—kidney cancer	0.00434	0.00729	CbGbCtD
Apixaban—CYP3A4—Sunitinib—kidney cancer	0.00362	0.00608	CbGbCtD
Apixaban—CYP3A4—Doxorubicin—kidney cancer	0.00271	0.00455	CbGbCtD
Apixaban—CYP2C19—urine—kidney cancer	0.00208	0.137	CbGeAlD
Apixaban—CYP1A2—urine—kidney cancer	0.0017	0.112	CbGeAlD
Apixaban—CYP2C9—urine—kidney cancer	0.00161	0.106	CbGeAlD
Apixaban—CYP2J2—nephron tubule—kidney cancer	0.00125	0.0827	CbGeAlD
Apixaban—F10—cardiac atrium—kidney cancer	0.00124	0.0822	CbGeAlD
Apixaban—CYP3A4—urine—kidney cancer	0.00123	0.0812	CbGeAlD
Apixaban—CYP2J2—cardiac atrium—kidney cancer	0.00102	0.0674	CbGeAlD
Apixaban—ABCG2—nephron tubule—kidney cancer	0.000474	0.0314	CbGeAlD
Apixaban—CYP2C8—renal system—kidney cancer	0.000443	0.0293	CbGeAlD
Apixaban—CYP3A5—nephron tubule—kidney cancer	0.00044	0.0291	CbGeAlD
Apixaban—CYP2C8—kidney—kidney cancer	0.000429	0.0284	CbGeAlD
Apixaban—CYP1A2—renal system—kidney cancer	0.000415	0.0274	CbGeAlD
Apixaban—CYP3A5—renal system—kidney cancer	0.0004	0.0265	CbGeAlD
Apixaban—CYP3A5—kidney—kidney cancer	0.000387	0.0256	CbGeAlD
Apixaban—CYP3A5—cortex of kidney—kidney cancer	0.000377	0.0249	CbGeAlD
Apixaban—CYP3A4—renal system—kidney cancer	0.0003	0.0199	CbGeAlD
Apixaban—CYP3A4—kidney—kidney cancer	0.00029	0.0192	CbGeAlD
Apixaban—Melaena—Capecitabine—kidney cancer	0.000272	0.00156	CcSEcCtD
Apixaban—Liver function test abnormal—Gemcitabine—kidney cancer	0.000272	0.00156	CcSEcCtD
Apixaban—Shock—Pazopanib—kidney cancer	0.000269	0.00154	CcSEcCtD
Apixaban—Nervous system disorder—Pazopanib—kidney cancer	0.000268	0.00154	CcSEcCtD
Apixaban—Thrombocytopenia—Pazopanib—kidney cancer	0.000268	0.00154	CcSEcCtD
Apixaban—Hepatobiliary disease—Sunitinib—kidney cancer	0.000267	0.00153	CcSEcCtD
Apixaban—Epistaxis—Sunitinib—kidney cancer	0.000267	0.00153	CcSEcCtD
Apixaban—Skin disorder—Pazopanib—kidney cancer	0.000266	0.00152	CcSEcCtD
Apixaban—Haemoglobin—Sorafenib—kidney cancer	0.000265	0.00152	CcSEcCtD
Apixaban—Aspartate aminotransferase increased—Gemcitabine—kidney cancer	0.000265	0.00152	CcSEcCtD
Apixaban—Mediastinal disorder—Erlotinib—kidney cancer	0.000264	0.00152	CcSEcCtD
Apixaban—Haemorrhage—Sorafenib—kidney cancer	0.000264	0.00151	CcSEcCtD
Apixaban—Urinary tract disorder—Sorafenib—kidney cancer	0.00026	0.0015	CcSEcCtD
Apixaban—Alanine aminotransferase increased—Gemcitabine—kidney cancer	0.00026	0.00149	CcSEcCtD
Apixaban—Connective tissue disorder—Sorafenib—kidney cancer	0.000259	0.00149	CcSEcCtD
Apixaban—Urethral disorder—Sorafenib—kidney cancer	0.000259	0.00148	CcSEcCtD
Apixaban—Haematemesis—Doxorubicin—kidney cancer	0.000258	0.00148	CcSEcCtD
Apixaban—Haemoglobin—Sunitinib—kidney cancer	0.000255	0.00146	CcSEcCtD
Apixaban—Haemorrhage—Sunitinib—kidney cancer	0.000254	0.00146	CcSEcCtD
Apixaban—Ecchymosis—Capecitabine—kidney cancer	0.000252	0.00145	CcSEcCtD
Apixaban—Urinary tract disorder—Sunitinib—kidney cancer	0.000251	0.00144	CcSEcCtD
Apixaban—Gastrointestinal disorder—Temsirolimus—kidney cancer	0.000251	0.00144	CcSEcCtD
Apixaban—Connective tissue disorder—Sunitinib—kidney cancer	0.000249	0.00143	CcSEcCtD
Apixaban—Urethral disorder—Sunitinib—kidney cancer	0.000249	0.00143	CcSEcCtD
Apixaban—Anaemia—Vinblastine—kidney cancer	0.000245	0.00141	CcSEcCtD
Apixaban—Anaemia—Everolimus—kidney cancer	0.000244	0.0014	CcSEcCtD
Apixaban—Vaginal haemorrhage—Doxorubicin—kidney cancer	0.000243	0.00139	CcSEcCtD
Apixaban—Haemoptysis—Doxorubicin—kidney cancer	0.000243	0.00139	CcSEcCtD
Apixaban—Angiopathy—Sorafenib—kidney cancer	0.000239	0.00137	CcSEcCtD
Apixaban—Immune system disorder—Sorafenib—kidney cancer	0.000238	0.00137	CcSEcCtD
Apixaban—Mediastinal disorder—Sorafenib—kidney cancer	0.000238	0.00136	CcSEcCtD
Apixaban—Syncope—Everolimus—kidney cancer	0.000237	0.00136	CcSEcCtD
Apixaban—Eye disorder—Sunitinib—kidney cancer	0.000237	0.00136	CcSEcCtD
Apixaban—Gastrointestinal disorder—Pazopanib—kidney cancer	0.000236	0.00135	CcSEcCtD
Apixaban—ABCB1—nephron tubule—kidney cancer	0.000234	0.0155	CbGeAlD
Apixaban—Blood alkaline phosphatase increased—Capecitabine—kidney cancer	0.000232	0.00133	CcSEcCtD
Apixaban—Diabetes mellitus—Capecitabine—kidney cancer	0.000232	0.00133	CcSEcCtD
Apixaban—Loss of consciousness—Everolimus—kidney cancer	0.000232	0.00133	CcSEcCtD
Apixaban—Angiopathy—Sunitinib—kidney cancer	0.00023	0.00132	CcSEcCtD
Apixaban—Immune system disorder—Sunitinib—kidney cancer	0.000229	0.00132	CcSEcCtD
Apixaban—Syncope—Erlotinib—kidney cancer	0.000229	0.00131	CcSEcCtD
Apixaban—Mediastinal disorder—Sunitinib—kidney cancer	0.000229	0.00131	CcSEcCtD
Apixaban—Liver function test abnormal—Paclitaxel—kidney cancer	0.000228	0.00131	CcSEcCtD
Apixaban—Loss of consciousness—Erlotinib—kidney cancer	0.000224	0.00129	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Everolimus—kidney cancer	0.000224	0.00128	CcSEcCtD
Apixaban—Breast disorder—Paclitaxel—kidney cancer	0.000223	0.00128	CcSEcCtD
Apixaban—Aspartate aminotransferase increased—Paclitaxel—kidney cancer	0.000222	0.00127	CcSEcCtD
Apixaban—Petechiae—Doxorubicin—kidney cancer	0.000218	0.00125	CcSEcCtD
Apixaban—Alanine aminotransferase increased—Paclitaxel—kidney cancer	0.000217	0.00125	CcSEcCtD
Apixaban—Haematuria—Gemcitabine—kidney cancer	0.000216	0.00124	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—kidney cancer	0.000216	0.00124	CcSEcCtD
Apixaban—Hepatobiliary disease—Gemcitabine—kidney cancer	0.000215	0.00123	CcSEcCtD
Apixaban—Hypersensitivity—Temsirolimus—kidney cancer	0.000214	0.00123	CcSEcCtD
Apixaban—ABCB1—renal system—kidney cancer	0.000213	0.0141	CbGeAlD
Apixaban—Shock—Everolimus—kidney cancer	0.000212	0.00122	CcSEcCtD
Apixaban—Anaemia—Sorafenib—kidney cancer	0.000212	0.00122	CcSEcCtD
Apixaban—Thrombocytopenia—Vinblastine—kidney cancer	0.000212	0.00122	CcSEcCtD
Apixaban—Urinary tract disorder—Vincristine—kidney cancer	0.000212	0.00122	CcSEcCtD
Apixaban—Nervous system disorder—Everolimus—kidney cancer	0.000212	0.00122	CcSEcCtD
Apixaban—Thrombocytopenia—Everolimus—kidney cancer	0.000211	0.00121	CcSEcCtD
Apixaban—Connective tissue disorder—Vincristine—kidney cancer	0.000211	0.00121	CcSEcCtD
Apixaban—Urethral disorder—Vincristine—kidney cancer	0.00021	0.00121	CcSEcCtD
Apixaban—Skin disorder—Everolimus—kidney cancer	0.00021	0.0012	CcSEcCtD
Apixaban—Syncope—Sorafenib—kidney cancer	0.000206	0.00118	CcSEcCtD
Apixaban—ABCB1—kidney—kidney cancer	0.000206	0.0136	CbGeAlD
Apixaban—Shock—Erlotinib—kidney cancer	0.000205	0.00118	CcSEcCtD
Apixaban—Haemoglobin—Gemcitabine—kidney cancer	0.000205	0.00117	CcSEcCtD
Apixaban—Nervous system disorder—Erlotinib—kidney cancer	0.000204	0.00117	CcSEcCtD
Apixaban—Anaemia—Sunitinib—kidney cancer	0.000204	0.00117	CcSEcCtD
Apixaban—Thrombocytopenia—Erlotinib—kidney cancer	0.000204	0.00117	CcSEcCtD
Apixaban—Haemorrhage—Gemcitabine—kidney cancer	0.000204	0.00117	CcSEcCtD
Apixaban—Skin disorder—Erlotinib—kidney cancer	0.000202	0.00116	CcSEcCtD
Apixaban—Gastrointestinal haemorrhage—Capecitabine—kidney cancer	0.000202	0.00116	CcSEcCtD
Apixaban—Loss of consciousness—Sorafenib—kidney cancer	0.000202	0.00116	CcSEcCtD
Apixaban—Hypotension—Everolimus—kidney cancer	0.000202	0.00116	CcSEcCtD
Apixaban—Urinary tract disorder—Gemcitabine—kidney cancer	0.000201	0.00115	CcSEcCtD
Apixaban—ABCB1—cortex of kidney—kidney cancer	0.0002	0.0132	CbGeAlD
Apixaban—Connective tissue disorder—Gemcitabine—kidney cancer	0.0002	0.00115	CcSEcCtD
Apixaban—Urethral disorder—Gemcitabine—kidney cancer	0.0002	0.00115	CcSEcCtD
Apixaban—Rectal haemorrhage—Doxorubicin—kidney cancer	0.000199	0.00114	CcSEcCtD
Apixaban—Angiopathy—Vincristine—kidney cancer	0.000195	0.00112	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—kidney cancer	0.000194	0.00111	CcSEcCtD
Apixaban—Mediastinal disorder—Vincristine—kidney cancer	0.000193	0.00111	CcSEcCtD
Apixaban—Anaemia—Dactinomycin—kidney cancer	0.000193	0.00111	CcSEcCtD
Apixaban—Dizziness—Temsirolimus—kidney cancer	0.000192	0.0011	CcSEcCtD
Apixaban—ABCB1—gonad—kidney cancer	0.000191	0.0126	CbGeAlD
Apixaban—Blood bilirubin increased—Doxorubicin—kidney cancer	0.00019	0.00109	CcSEcCtD
Apixaban—Anaphylactic shock—Sorafenib—kidney cancer	0.000187	0.00108	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—kidney cancer	0.000187	0.00107	CcSEcCtD
Apixaban—Liver function test abnormal—Capecitabine—kidney cancer	0.000187	0.00107	CcSEcCtD
Apixaban—Gastrointestinal disorder—Everolimus—kidney cancer	0.000186	0.00107	CcSEcCtD
Apixaban—Angiopathy—Gemcitabine—kidney cancer	0.000185	0.00106	CcSEcCtD
Apixaban—Shock—Sorafenib—kidney cancer	0.000184	0.00106	CcSEcCtD
Apixaban—Immune system disorder—Gemcitabine—kidney cancer	0.000184	0.00106	CcSEcCtD
Apixaban—Nervous system disorder—Sorafenib—kidney cancer	0.000184	0.00105	CcSEcCtD
Apixaban—Mediastinal disorder—Gemcitabine—kidney cancer	0.000184	0.00105	CcSEcCtD
Apixaban—Thrombocytopenia—Sorafenib—kidney cancer	0.000183	0.00105	CcSEcCtD
Apixaban—Rash—Temsirolimus—kidney cancer	0.000183	0.00105	CcSEcCtD
Apixaban—Dermatitis—Temsirolimus—kidney cancer	0.000183	0.00105	CcSEcCtD
Apixaban—Breast disorder—Capecitabine—kidney cancer	0.000183	0.00105	CcSEcCtD
Apixaban—Aspartate aminotransferase increased—Capecitabine—kidney cancer	0.000182	0.00105	CcSEcCtD
Apixaban—Skin disorder—Sorafenib—kidney cancer	0.000182	0.00104	CcSEcCtD
Apixaban—Haematuria—Paclitaxel—kidney cancer	0.000181	0.00104	CcSEcCtD
Apixaban—Dizziness—Pazopanib—kidney cancer	0.000181	0.00104	CcSEcCtD
Apixaban—Gastrointestinal disorder—Erlotinib—kidney cancer	0.00018	0.00103	CcSEcCtD
Apixaban—Hepatobiliary disease—Paclitaxel—kidney cancer	0.00018	0.00103	CcSEcCtD
Apixaban—Epistaxis—Paclitaxel—kidney cancer	0.000179	0.00103	CcSEcCtD
Apixaban—Alanine aminotransferase increased—Capecitabine—kidney cancer	0.000178	0.00102	CcSEcCtD
Apixaban—Shock—Sunitinib—kidney cancer	0.000177	0.00102	CcSEcCtD
Apixaban—Nervous system disorder—Sunitinib—kidney cancer	0.000177	0.00101	CcSEcCtD
Apixaban—Thrombocytopenia—Sunitinib—kidney cancer	0.000177	0.00101	CcSEcCtD
Apixaban—Melaena—Doxorubicin—kidney cancer	0.000175	0.00101	CcSEcCtD
Apixaban—Skin disorder—Sunitinib—kidney cancer	0.000175	0.00101	CcSEcCtD
Apixaban—Anaemia—Vincristine—kidney cancer	0.000173	0.000991	CcSEcCtD
Apixaban—Rash—Pazopanib—kidney cancer	0.000172	0.000989	CcSEcCtD
Apixaban—Nausea—Temsirolimus—kidney cancer	0.000172	0.000989	CcSEcCtD
Apixaban—Dermatitis—Pazopanib—kidney cancer	0.000172	0.000989	CcSEcCtD
Apixaban—Haemoglobin—Paclitaxel—kidney cancer	0.000171	0.000984	CcSEcCtD
Apixaban—Haemorrhage—Paclitaxel—kidney cancer	0.00017	0.000979	CcSEcCtD
Apixaban—Urinary tract disorder—Paclitaxel—kidney cancer	0.000168	0.000966	CcSEcCtD
Apixaban—Connective tissue disorder—Paclitaxel—kidney cancer	0.000168	0.000962	CcSEcCtD
Apixaban—Urethral disorder—Paclitaxel—kidney cancer	0.000167	0.000959	CcSEcCtD
Apixaban—Thrombocytopenia—Dactinomycin—kidney cancer	0.000167	0.000959	CcSEcCtD
Apixaban—Anaemia—Gemcitabine—kidney cancer	0.000164	0.00094	CcSEcCtD
Apixaban—Nausea—Pazopanib—kidney cancer	0.000162	0.000932	CcSEcCtD
Apixaban—Ecchymosis—Doxorubicin—kidney cancer	0.000162	0.000932	CcSEcCtD
Apixaban—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000162	0.000929	CcSEcCtD
Apixaban—Hypersensitivity—Vinblastine—kidney cancer	0.00016	0.000916	CcSEcCtD
Apixaban—Eye disorder—Paclitaxel—kidney cancer	0.000159	0.000915	CcSEcCtD
Apixaban—Hypersensitivity—Everolimus—kidney cancer	0.000159	0.000913	CcSEcCtD
Apixaban—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000156	0.000893	CcSEcCtD
Apixaban—Angiopathy—Paclitaxel—kidney cancer	0.000155	0.000888	CcSEcCtD
Apixaban—Immune system disorder—Paclitaxel—kidney cancer	0.000154	0.000884	CcSEcCtD
Apixaban—Mediastinal disorder—Paclitaxel—kidney cancer	0.000154	0.000882	CcSEcCtD
Apixaban—Anaphylactic shock—Vincristine—kidney cancer	0.000152	0.000875	CcSEcCtD
Apixaban—Blood alkaline phosphatase increased—Doxorubicin—kidney cancer	0.00015	0.00086	CcSEcCtD
Apixaban—Diabetes mellitus—Doxorubicin—kidney cancer	0.00015	0.00086	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.00015	0.00086	CcSEcCtD
Apixaban—Nervous system disorder—Vincristine—kidney cancer	0.00015	0.000858	CcSEcCtD
Apixaban—Thrombocytopenia—Vincristine—kidney cancer	0.000149	0.000857	CcSEcCtD
Apixaban—Haematuria—Capecitabine—kidney cancer	0.000149	0.000853	CcSEcCtD
Apixaban—Hepatobiliary disease—Capecitabine—kidney cancer	0.000147	0.000846	CcSEcCtD
Apixaban—Epistaxis—Capecitabine—kidney cancer	0.000147	0.000844	CcSEcCtD
Apixaban—Anaphylactic shock—Gemcitabine—kidney cancer	0.000145	0.00083	CcSEcCtD
Apixaban—Dizziness—Vinblastine—kidney cancer	0.000143	0.000823	CcSEcCtD
Apixaban—Dizziness—Everolimus—kidney cancer	0.000143	0.000819	CcSEcCtD
Apixaban—Hypotension—Vincristine—kidney cancer	0.000142	0.000818	CcSEcCtD
Apixaban—Nervous system disorder—Gemcitabine—kidney cancer	0.000142	0.000814	CcSEcCtD
Apixaban—Thrombocytopenia—Gemcitabine—kidney cancer	0.000142	0.000813	CcSEcCtD
Apixaban—Haemoglobin—Capecitabine—kidney cancer	0.000141	0.000807	CcSEcCtD
Apixaban—Skin disorder—Gemcitabine—kidney cancer	0.000141	0.000807	CcSEcCtD
Apixaban—Haemorrhage—Capecitabine—kidney cancer	0.00014	0.000803	CcSEcCtD
Apixaban—Urinary tract disorder—Capecitabine—kidney cancer	0.000138	0.000793	CcSEcCtD
Apixaban—Hypersensitivity—Sorafenib—kidney cancer	0.000138	0.000792	CcSEcCtD
Apixaban—Dizziness—Erlotinib—kidney cancer	0.000138	0.000791	CcSEcCtD
Apixaban—Connective tissue disorder—Capecitabine—kidney cancer	0.000137	0.000789	CcSEcCtD
Apixaban—Anaemia—Paclitaxel—kidney cancer	0.000137	0.000787	CcSEcCtD
Apixaban—Urethral disorder—Capecitabine—kidney cancer	0.000137	0.000787	CcSEcCtD
Apixaban—Rash—Everolimus—kidney cancer	0.000136	0.000781	CcSEcCtD
Apixaban—Dermatitis—Everolimus—kidney cancer	0.000136	0.000781	CcSEcCtD
Apixaban—Hypotension—Gemcitabine—kidney cancer	0.000135	0.000776	CcSEcCtD
Apixaban—Syncope—Paclitaxel—kidney cancer	0.000133	0.000764	CcSEcCtD
Apixaban—Hypersensitivity—Sunitinib—kidney cancer	0.000133	0.000762	CcSEcCtD
Apixaban—Gastrointestinal disorder—Vincristine—kidney cancer	0.000132	0.000756	CcSEcCtD
Apixaban—Rash—Erlotinib—kidney cancer	0.000131	0.000754	CcSEcCtD
Apixaban—Dermatitis—Erlotinib—kidney cancer	0.000131	0.000753	CcSEcCtD
Apixaban—Eye disorder—Capecitabine—kidney cancer	0.000131	0.000751	CcSEcCtD
Apixaban—Loss of consciousness—Paclitaxel—kidney cancer	0.00013	0.000749	CcSEcCtD
Apixaban—Gastrointestinal haemorrhage—Doxorubicin—kidney cancer	0.00013	0.000748	CcSEcCtD
Apixaban—Nausea—Vinblastine—kidney cancer	0.000129	0.000739	CcSEcCtD
Apixaban—Nausea—Everolimus—kidney cancer	0.000128	0.000736	CcSEcCtD
Apixaban—Angiopathy—Capecitabine—kidney cancer	0.000127	0.000729	CcSEcCtD
Apixaban—Immune system disorder—Capecitabine—kidney cancer	0.000126	0.000725	CcSEcCtD
Apixaban—Mediastinal disorder—Capecitabine—kidney cancer	0.000126	0.000724	CcSEcCtD
Apixaban—Hypersensitivity—Dactinomycin—kidney cancer	0.000126	0.000722	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000125	0.00072	CcSEcCtD
Apixaban—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000125	0.000717	CcSEcCtD
Apixaban—Dizziness—Sorafenib—kidney cancer	0.000124	0.000711	CcSEcCtD
Apixaban—Nausea—Erlotinib—kidney cancer	0.000124	0.00071	CcSEcCtD
Apixaban—Anaphylactic shock—Paclitaxel—kidney cancer	0.000121	0.000695	CcSEcCtD
Apixaban—Liver function test abnormal—Doxorubicin—kidney cancer	0.00012	0.000691	CcSEcCtD
Apixaban—Dizziness—Sunitinib—kidney cancer	0.000119	0.000684	CcSEcCtD
Apixaban—Shock—Paclitaxel—kidney cancer	0.000119	0.000684	CcSEcCtD
Apixaban—Nervous system disorder—Paclitaxel—kidney cancer	0.000119	0.000682	CcSEcCtD
Apixaban—Thrombocytopenia—Paclitaxel—kidney cancer	0.000119	0.000681	CcSEcCtD
Apixaban—Rash—Sorafenib—kidney cancer	0.000118	0.000678	CcSEcCtD
Apixaban—Dermatitis—Sorafenib—kidney cancer	0.000118	0.000678	CcSEcCtD
Apixaban—Breast disorder—Doxorubicin—kidney cancer	0.000118	0.000676	CcSEcCtD
Apixaban—Skin disorder—Paclitaxel—kidney cancer	0.000118	0.000675	CcSEcCtD
Apixaban—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	0.000117	0.000674	CcSEcCtD
Apixaban—Alanine aminotransferase increased—Doxorubicin—kidney cancer	0.000115	0.00066	CcSEcCtD
Apixaban—Rash—Sunitinib—kidney cancer	0.000114	0.000653	CcSEcCtD
Apixaban—Dermatitis—Sunitinib—kidney cancer	0.000114	0.000652	CcSEcCtD
Apixaban—Hypotension—Paclitaxel—kidney cancer	0.000113	0.00065	CcSEcCtD
Apixaban—Anaemia—Capecitabine—kidney cancer	0.000113	0.000646	CcSEcCtD
Apixaban—Hypersensitivity—Vincristine—kidney cancer	0.000112	0.000645	CcSEcCtD
Apixaban—Nausea—Sorafenib—kidney cancer	0.000111	0.000639	CcSEcCtD
Apixaban—Syncope—Capecitabine—kidney cancer	0.000109	0.000627	CcSEcCtD
Apixaban—Rash—Dactinomycin—kidney cancer	0.000108	0.000618	CcSEcCtD
Apixaban—Nausea—Sunitinib—kidney cancer	0.000107	0.000615	CcSEcCtD
Apixaban—Loss of consciousness—Capecitabine—kidney cancer	0.000107	0.000614	CcSEcCtD
Apixaban—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000105	0.0006	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000103	0.000591	CcSEcCtD
Apixaban—Nausea—Dactinomycin—kidney cancer	0.000101	0.000582	CcSEcCtD
Apixaban—Dizziness—Vincristine—kidney cancer	0.000101	0.000579	CcSEcCtD
Apixaban—Shock—Capecitabine—kidney cancer	9.78e-05	0.000561	CcSEcCtD
Apixaban—Nervous system disorder—Capecitabine—kidney cancer	9.75e-05	0.00056	CcSEcCtD
Apixaban—Thrombocytopenia—Capecitabine—kidney cancer	9.73e-05	0.000559	CcSEcCtD
Apixaban—Skin disorder—Capecitabine—kidney cancer	9.65e-05	0.000554	CcSEcCtD
Apixaban—Rash—Vincristine—kidney cancer	9.61e-05	0.000552	CcSEcCtD
Apixaban—Dermatitis—Vincristine—kidney cancer	9.61e-05	0.000551	CcSEcCtD
Apixaban—Haematuria—Doxorubicin—kidney cancer	9.58e-05	0.00055	CcSEcCtD
Apixaban—Hepatobiliary disease—Doxorubicin—kidney cancer	9.5e-05	0.000545	CcSEcCtD
Apixaban—Epistaxis—Doxorubicin—kidney cancer	9.48e-05	0.000544	CcSEcCtD
Apixaban—Hypotension—Capecitabine—kidney cancer	9.29e-05	0.000533	CcSEcCtD
Apixaban—Rash—Gemcitabine—kidney cancer	9.12e-05	0.000524	CcSEcCtD
Apixaban—Dermatitis—Gemcitabine—kidney cancer	9.11e-05	0.000523	CcSEcCtD
Apixaban—Haemoglobin—Doxorubicin—kidney cancer	9.06e-05	0.00052	CcSEcCtD
Apixaban—Nausea—Vincristine—kidney cancer	9.06e-05	0.00052	CcSEcCtD
Apixaban—Haemorrhage—Doxorubicin—kidney cancer	9.02e-05	0.000518	CcSEcCtD
Apixaban—Hypersensitivity—Paclitaxel—kidney cancer	8.92e-05	0.000512	CcSEcCtD
Apixaban—Urinary tract disorder—Doxorubicin—kidney cancer	8.91e-05	0.000511	CcSEcCtD
Apixaban—Connective tissue disorder—Doxorubicin—kidney cancer	8.86e-05	0.000509	CcSEcCtD
Apixaban—Urethral disorder—Doxorubicin—kidney cancer	8.84e-05	0.000507	CcSEcCtD
Apixaban—Nausea—Gemcitabine—kidney cancer	8.59e-05	0.000493	CcSEcCtD
Apixaban—Gastrointestinal disorder—Capecitabine—kidney cancer	8.58e-05	0.000493	CcSEcCtD
Apixaban—Eye disorder—Doxorubicin—kidney cancer	8.43e-05	0.000484	CcSEcCtD
Apixaban—Angiopathy—Doxorubicin—kidney cancer	8.18e-05	0.00047	CcSEcCtD
Apixaban—Immune system disorder—Doxorubicin—kidney cancer	8.15e-05	0.000468	CcSEcCtD
Apixaban—Mediastinal disorder—Doxorubicin—kidney cancer	8.13e-05	0.000467	CcSEcCtD
Apixaban—Dizziness—Paclitaxel—kidney cancer	8.01e-05	0.00046	CcSEcCtD
Apixaban—Rash—Paclitaxel—kidney cancer	7.64e-05	0.000438	CcSEcCtD
Apixaban—Dermatitis—Paclitaxel—kidney cancer	7.63e-05	0.000438	CcSEcCtD
Apixaban—Hypersensitivity—Capecitabine—kidney cancer	7.32e-05	0.00042	CcSEcCtD
Apixaban—Anaemia—Doxorubicin—kidney cancer	7.26e-05	0.000417	CcSEcCtD
Apixaban—Nausea—Paclitaxel—kidney cancer	7.19e-05	0.000413	CcSEcCtD
Apixaban—Syncope—Doxorubicin—kidney cancer	7.04e-05	0.000404	CcSEcCtD
Apixaban—Loss of consciousness—Doxorubicin—kidney cancer	6.9e-05	0.000396	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	6.64e-05	0.000381	CcSEcCtD
Apixaban—Dizziness—Capecitabine—kidney cancer	6.57e-05	0.000377	CcSEcCtD
Apixaban—Anaphylactic shock—Doxorubicin—kidney cancer	6.41e-05	0.000368	CcSEcCtD
Apixaban—Shock—Doxorubicin—kidney cancer	6.3e-05	0.000362	CcSEcCtD
Apixaban—Nervous system disorder—Doxorubicin—kidney cancer	6.28e-05	0.000361	CcSEcCtD
Apixaban—Thrombocytopenia—Doxorubicin—kidney cancer	6.27e-05	0.00036	CcSEcCtD
Apixaban—Rash—Capecitabine—kidney cancer	6.27e-05	0.00036	CcSEcCtD
Apixaban—Dermatitis—Capecitabine—kidney cancer	6.26e-05	0.000359	CcSEcCtD
Apixaban—Skin disorder—Doxorubicin—kidney cancer	6.22e-05	0.000357	CcSEcCtD
Apixaban—Hypotension—Doxorubicin—kidney cancer	5.99e-05	0.000344	CcSEcCtD
Apixaban—Nausea—Capecitabine—kidney cancer	5.9e-05	0.000339	CcSEcCtD
Apixaban—Gastrointestinal disorder—Doxorubicin—kidney cancer	5.53e-05	0.000318	CcSEcCtD
Apixaban—Hypersensitivity—Doxorubicin—kidney cancer	4.72e-05	0.000271	CcSEcCtD
Apixaban—Dizziness—Doxorubicin—kidney cancer	4.24e-05	0.000243	CcSEcCtD
Apixaban—Rash—Doxorubicin—kidney cancer	4.04e-05	0.000232	CcSEcCtD
Apixaban—Dermatitis—Doxorubicin—kidney cancer	4.04e-05	0.000232	CcSEcCtD
Apixaban—Nausea—Doxorubicin—kidney cancer	3.81e-05	0.000218	CcSEcCtD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	1.59e-05	0.000294	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—GPC3—kidney cancer	1.59e-05	0.000293	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ACY1—kidney cancer	1.57e-05	0.000291	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—GPC3—kidney cancer	1.55e-05	0.000286	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—CA2—kidney cancer	1.54e-05	0.000285	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—SLC5A3—kidney cancer	1.54e-05	0.000285	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PGK1—kidney cancer	1.54e-05	0.000285	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—APRT—kidney cancer	1.54e-05	0.000284	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—FH—kidney cancer	1.54e-05	0.000284	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—GSTT1—kidney cancer	1.52e-05	0.000281	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—ACHE—kidney cancer	1.52e-05	0.000281	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—CA9—kidney cancer	1.51e-05	0.00028	CbGpPWpGaD
Apixaban—ABCB1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	1.51e-05	0.000279	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—LDHB—kidney cancer	1.51e-05	0.000279	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CA2—kidney cancer	1.51e-05	0.000278	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	1.5e-05	0.000278	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—ALAD—kidney cancer	1.5e-05	0.000278	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.5e-05	0.000278	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	1.47e-05	0.000273	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—ST3GAL2—kidney cancer	1.47e-05	0.000271	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—ALAD—kidney cancer	1.47e-05	0.000271	CbGpPWpGaD
Apixaban—ABCB1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	1.46e-05	0.00027	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—GPC3—kidney cancer	1.45e-05	0.000267	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—SCARB1—kidney cancer	1.44e-05	0.000266	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	1.44e-05	0.000265	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—ALDH1A1—kidney cancer	1.43e-05	0.000265	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—ST3GAL2—kidney cancer	1.43e-05	0.000265	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	1.43e-05	0.000265	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PTGS1—kidney cancer	1.43e-05	0.000264	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	1.42e-05	0.000263	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PPAT—kidney cancer	1.41e-05	0.000261	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—GLIPR1—kidney cancer	1.41e-05	0.000261	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CA2—kidney cancer	1.41e-05	0.00026	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—ALDH1A1—kidney cancer	1.4e-05	0.000259	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PSMD7—kidney cancer	1.4e-05	0.000259	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.4e-05	0.000258	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	1.39e-05	0.000256	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.38e-05	0.000256	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PGK1—kidney cancer	1.37e-05	0.000254	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—SLC5A3—kidney cancer	1.37e-05	0.000254	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—ALAD—kidney cancer	1.37e-05	0.000254	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—PTGS2—kidney cancer	1.36e-05	0.000251	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—LDHB—kidney cancer	1.35e-05	0.000249	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—SLC5A3—kidney cancer	1.34e-05	0.000248	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PGK1—kidney cancer	1.34e-05	0.000248	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PDHB—kidney cancer	1.34e-05	0.000248	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—ST3GAL2—kidney cancer	1.34e-05	0.000247	CbGpPWpGaD
Apixaban—CYP3A4—Biological oxidations—POMC—kidney cancer	1.33e-05	0.000247	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—BCHE—kidney cancer	1.33e-05	0.000245	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—LDHB—kidney cancer	1.32e-05	0.000243	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—APRT—kidney cancer	1.31e-05	0.000243	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—FH—kidney cancer	1.31e-05	0.000243	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—CA9—kidney cancer	1.31e-05	0.000242	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—SLC5A5—kidney cancer	1.31e-05	0.000242	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—ALDH1A1—kidney cancer	1.31e-05	0.000242	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—CRABP1—kidney cancer	1.29e-05	0.000238	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.28e-05	0.000238	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.28e-05	0.000237	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—SLC2A1—kidney cancer	1.26e-05	0.000234	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CCBL1—kidney cancer	1.26e-05	0.000233	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PGK1—kidney cancer	1.25e-05	0.000232	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—SLC5A3—kidney cancer	1.25e-05	0.000232	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	1.25e-05	0.000231	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—GPC3—kidney cancer	1.24e-05	0.000229	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—LDHB—kidney cancer	1.23e-05	0.000227	CbGpPWpGaD
Apixaban—ABCG2—Transmembrane transport of small molecules—RAF1—kidney cancer	1.21e-05	0.000223	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CA2—kidney cancer	1.2e-05	0.000222	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—ITPR2—kidney cancer	1.2e-05	0.000221	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—PTEN—kidney cancer	1.18e-05	0.000219	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	1.18e-05	0.000219	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ALAD—kidney cancer	1.17e-05	0.000217	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—CA9—kidney cancer	1.17e-05	0.000216	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	1.15e-05	0.000213	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ST3GAL2—kidney cancer	1.14e-05	0.000211	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.14e-05	0.000211	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CA9—kidney cancer	1.14e-05	0.000211	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	1.13e-05	0.000208	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ALDH1A1—kidney cancer	1.12e-05	0.000207	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—CRABP1—kidney cancer	1.11e-05	0.000206	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GLIPR1—kidney cancer	1.09e-05	0.000202	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PPAT—kidney cancer	1.09e-05	0.000202	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—GSTT1—kidney cancer	1.09e-05	0.000202	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—ACHE—kidney cancer	1.09e-05	0.000202	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—SLC5A3—kidney cancer	1.07e-05	0.000198	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PGK1—kidney cancer	1.07e-05	0.000198	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CA9—kidney cancer	1.07e-05	0.000197	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	1.06e-05	0.000197	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—GSTP1—kidney cancer	1.05e-05	0.000195	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—LDHB—kidney cancer	1.05e-05	0.000194	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.04e-05	0.000193	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—ITPR2—kidney cancer	1.04e-05	0.000191	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—SCARB1—kidney cancer	1.03e-05	0.000191	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PTGS1—kidney cancer	1.02e-05	0.000189	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—FH—kidney cancer	1.01e-05	0.000188	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—APRT—kidney cancer	1.01e-05	0.000188	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PSMD7—kidney cancer	1e-05	0.000185	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—ABCB1—kidney cancer	9.98e-06	0.000185	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—CRABP1—kidney cancer	9.94e-06	0.000184	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	9.77e-06	0.000181	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CRABP1—kidney cancer	9.7e-06	0.000179	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—GSTM1—kidney cancer	9.69e-06	0.000179	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	9.54e-06	0.000177	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GPC3—kidney cancer	9.54e-06	0.000176	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—BCHE—kidney cancer	9.5e-06	0.000176	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	9.45e-06	0.000175	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—GSTT1—kidney cancer	9.44e-06	0.000175	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—ACHE—kidney cancer	9.44e-06	0.000175	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—SLC5A5—kidney cancer	9.38e-06	0.000173	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CA2—kidney cancer	9.28e-06	0.000172	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—ITPR2—kidney cancer	9.24e-06	0.000171	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—CYP1A1—kidney cancer	9.19e-06	0.00017	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CA9—kidney cancer	9.11e-06	0.000168	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CRABP1—kidney cancer	9.06e-06	0.000168	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—SLC2A1—kidney cancer	9.06e-06	0.000168	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ALAD—kidney cancer	9.04e-06	0.000167	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—ITPR2—kidney cancer	9.02e-06	0.000167	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—SCARB1—kidney cancer	8.94e-06	0.000165	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	8.9e-06	0.000165	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PTGS1—kidney cancer	8.85e-06	0.000164	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ST3GAL2—kidney cancer	8.82e-06	0.000163	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PSMD7—kidney cancer	8.68e-06	0.00016	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ALDH1A1—kidney cancer	8.62e-06	0.000159	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	8.52e-06	0.000158	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—GSTT1—kidney cancer	8.43e-06	0.000156	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—ACHE—kidney cancer	8.43e-06	0.000156	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—ITPR2—kidney cancer	8.43e-06	0.000156	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—PIK3CA—kidney cancer	8.36e-06	0.000155	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PGK1—kidney cancer	8.27e-06	0.000153	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—SLC5A3—kidney cancer	8.27e-06	0.000153	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—ACHE—kidney cancer	8.23e-06	0.000152	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—GSTT1—kidney cancer	8.23e-06	0.000152	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—BCHE—kidney cancer	8.23e-06	0.000152	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—SLC5A5—kidney cancer	8.12e-06	0.00015	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—LDHB—kidney cancer	8.11e-06	0.00015	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—SCARB1—kidney cancer	7.98e-06	0.000148	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PTGS1—kidney cancer	7.9e-06	0.000146	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—SLC2A1—kidney cancer	7.85e-06	0.000145	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—SCARB1—kidney cancer	7.79e-06	0.000144	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	7.77e-06	0.000144	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CRABP1—kidney cancer	7.75e-06	0.000143	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PSMD7—kidney cancer	7.74e-06	0.000143	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PTGS1—kidney cancer	7.71e-06	0.000143	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—GSTT1—kidney cancer	7.68e-06	0.000142	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—ACHE—kidney cancer	7.68e-06	0.000142	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	7.61e-06	0.000141	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PSMD7—kidney cancer	7.56e-06	0.00014	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—GSTP1—kidney cancer	7.56e-06	0.00014	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—BCHE—kidney cancer	7.34e-06	0.000136	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—SCARB1—kidney cancer	7.27e-06	0.000135	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—SLC5A5—kidney cancer	7.25e-06	0.000134	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ITPR2—kidney cancer	7.2e-06	0.000133	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PTGS1—kidney cancer	7.2e-06	0.000133	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—BCHE—kidney cancer	7.17e-06	0.000133	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—ABCB1—kidney cancer	7.15e-06	0.000132	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—SLC5A5—kidney cancer	7.08e-06	0.000131	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PSMD7—kidney cancer	7.06e-06	0.000131	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CA9—kidney cancer	7.03e-06	0.00013	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—SLC2A1—kidney cancer	7e-06	0.00013	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—GSTM1—kidney cancer	6.94e-06	0.000128	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—POMC—kidney cancer	6.85e-06	0.000127	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—SLC2A1—kidney cancer	6.84e-06	0.000126	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	6.8e-06	0.000126	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—BCHE—kidney cancer	6.69e-06	0.000124	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	6.64e-06	0.000123	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	6.64e-06	0.000123	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—SLC5A5—kidney cancer	6.61e-06	0.000122	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—CYP1A1—kidney cancer	6.58e-06	0.000122	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—GSTT1—kidney cancer	6.57e-06	0.000121	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ACHE—kidney cancer	6.57e-06	0.000121	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—GSTP1—kidney cancer	6.54e-06	0.000121	CbGpPWpGaD
Apixaban—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	6.52e-06	0.000121	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—SLC2A1—kidney cancer	6.39e-06	0.000118	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—SCARB1—kidney cancer	6.22e-06	0.000115	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	6.2e-06	0.000115	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—ABCB1—kidney cancer	6.2e-06	0.000115	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PTGS1—kidney cancer	6.15e-06	0.000114	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PSMD7—kidney cancer	6.03e-06	0.000112	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—GSTM1—kidney cancer	6.01e-06	0.000111	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CRABP1—kidney cancer	5.98e-06	0.000111	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	5.93e-06	0.00011	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—GSTP1—kidney cancer	5.84e-06	0.000108	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—BCHE—kidney cancer	5.72e-06	0.000106	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—GSTP1—kidney cancer	5.7e-06	0.000105	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—CYP1A1—kidney cancer	5.7e-06	0.000105	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—SLC5A5—kidney cancer	5.65e-06	0.000104	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ITPR2—kidney cancer	5.56e-06	0.000103	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—ABCB1—kidney cancer	5.53e-06	0.000102	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PTGS2—kidney cancer	5.46e-06	0.000101	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—SLC2A1—kidney cancer	5.46e-06	0.000101	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	5.4e-06	9.99e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—GSTM1—kidney cancer	5.37e-06	9.93e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—GSTP1—kidney cancer	5.33e-06	9.85e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	5.29e-06	9.79e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—GSTM1—kidney cancer	5.24e-06	9.69e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—CYP1A1—kidney cancer	5.09e-06	9.41e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GSTT1—kidney cancer	5.07e-06	9.37e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ACHE—kidney cancer	5.07e-06	9.37e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—ABCB1—kidney cancer	5.04e-06	9.32e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CYP1A1—kidney cancer	4.97e-06	9.19e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—POMC—kidney cancer	4.91e-06	9.08e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—GSTM1—kidney cancer	4.89e-06	9.05e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—SCARB1—kidney cancer	4.8e-06	8.87e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PTEN—kidney cancer	4.76e-06	8.81e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PTGS1—kidney cancer	4.75e-06	8.78e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.68e-06	8.66e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PSMD7—kidney cancer	4.66e-06	8.61e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CYP1A1—kidney cancer	4.64e-06	8.58e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	4.62e-06	8.54e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—GSTP1—kidney cancer	4.55e-06	8.42e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—BCHE—kidney cancer	4.41e-06	8.16e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—SLC5A5—kidney cancer	4.36e-06	8.06e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ABCB1—kidney cancer	4.31e-06	7.97e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—POMC—kidney cancer	4.25e-06	7.86e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—SLC2A1—kidney cancer	4.21e-06	7.79e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—GSTM1—kidney cancer	4.18e-06	7.74e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.18e-06	7.73e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CYP1A1—kidney cancer	3.97e-06	7.33e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PTGS2—kidney cancer	3.91e-06	7.24e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.81e-06	7.05e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—POMC—kidney cancer	3.79e-06	7.02e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—POMC—kidney cancer	3.7e-06	6.85e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GSTP1—kidney cancer	3.51e-06	6.5e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—POMC—kidney cancer	3.46e-06	6.4e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PTEN—kidney cancer	3.41e-06	6.31e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PTGS2—kidney cancer	3.39e-06	6.27e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PIK3CA—kidney cancer	3.36e-06	6.22e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ABCB1—kidney cancer	3.33e-06	6.15e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.26e-06	6.02e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GSTM1—kidney cancer	3.23e-06	5.97e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CYP1A1—kidney cancer	3.06e-06	5.66e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PTGS2—kidney cancer	3.03e-06	5.6e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PTEN—kidney cancer	2.96e-06	5.47e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—POMC—kidney cancer	2.96e-06	5.47e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PTGS2—kidney cancer	2.95e-06	5.46e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PTGS2—kidney cancer	2.76e-06	5.1e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PTEN—kidney cancer	2.64e-06	4.88e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PTEN—kidney cancer	2.58e-06	4.76e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PIK3CA—kidney cancer	2.41e-06	4.45e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PTEN—kidney cancer	2.41e-06	4.45e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PTGS2—kidney cancer	2.36e-06	4.36e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—POMC—kidney cancer	2.28e-06	4.22e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PIK3CA—kidney cancer	2.09e-06	3.86e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PTEN—kidney cancer	2.06e-06	3.8e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PIK3CA—kidney cancer	1.86e-06	3.44e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PTGS2—kidney cancer	1.82e-06	3.37e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PIK3CA—kidney cancer	1.82e-06	3.36e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PIK3CA—kidney cancer	1.7e-06	3.14e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PTEN—kidney cancer	1.59e-06	2.94e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PIK3CA—kidney cancer	1.45e-06	2.68e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.12e-06	2.07e-05	CbGpPWpGaD
